Journals / Haseki Tıp Bülteni / 2020 / Cilt: 58 - Sayı: 2

Evaluation of Non-specific Cerebral White Matter Lesions and Related Factors in Patients with Migraine with Aura

Auralı Migren Hastalarında Non-spesifik Serebral Ak Madde Lezyonlarının Varlığı ve İlişkili Faktörlerin Değerlendirilmesi

Pages
122–128
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our results show a significant increase in nonspecific WMLs in patients with MWA.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Cerebral white matter hyperintensities (WMLs) are known to be observed in migraine patients but there only are a handful of studies focused on WMLs in migraine with aura (MWA).
📊
Key Findings & Data:Methods: A total of 112 patients diagnosed with migraine were enrolled.
💡
Conclusion & Impact:Conclusion: Our results show a significant increase in nonspecific WMLs in patients with MWA.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Cerebral white matter hyperintensities (WMLs) are known to be observed in migraine patients but there only are a handful of studies focused on WMLs in migraine with aura (MWA). In this study, we aimed to investigate the frequency of WML and demographic and environmental factors associated with WML in patients with MWA. Methods: A total of 112 patients diagnosed with migraine were enrolled. Detailed systemic and neurological examinations, blood pressure, weight and height measurements, presence of hypertension, smoking status, clinical and demographical data and visual analog scale, allodynia symptom checklist (ASC) and migraine disability assessment scale scores were recorded. The migraine groups with and without aura were compared statistically. A logistic regression analysis was performed to analyse the risk factors for the development of WMLs. Results: Supratentorial and periventricular WMLs were more frequent in patients with MWA (p=0.008). Presence of aura and longer disease duration were independent risk factors for the development of WMLs (p=0.0020 and p=0.019, respectively). Migraine attack frequency, and ASC scores were higher in patients with MWA (p=0.005, p=0.015 and p<0.001, respectively). Conclusion: Our results show a significant increase in nonspecific WMLs in patients with MWA. A longer disease duration and presence of aura are significant risk factors for development of these lesions. Our findings warrant further research to validate our result.

Özet

Amaç: Migren hastalarında serebral ak madde lezyonlarına (AML) rastlanabildiği iyi bilinmekle birlikte, auralı migren (MWA) hastalarında AML’nin varlığı üzerine yoğunlaşmış sınırlı sayıda çalışma bulunmaktadır. Bu çalışmada amacımız MWA hastalarında non-spesifik AML’nin sıklığı ve ilişkili demografik ve çevresel faktörlerin araştırılmasıdır. Yöntemler: Uluslararası Baş Ağrısı Topluluğu kriterlerine (ICHD3) göre migren tanısı almış toplam 112 hasta çalışmaya dahil edildi. Detaylı sistemik ve nörolojik muayeneleri, kan basıncı, kilo, boy ölçümleri, hipertansiyon ve sigara kullanımları, klinik ve demografik bilgileri, görsel analog skala, allodini semptom kontrol anketi (ASK) ve migren dizabilite ölçeği skorları kaydedildi. Auralı ve aurasız migren grupları istatistiksel olarak karşılaştırıldı. AML oluşumuna etki edebilen bağımsız risk faktörlerinin analizi için ek olarak lojistik regresyon analizi uygulandı. Bulgular: Süpratentoryal ve periventriküler non-spesifik AML, MWA grubunda aurasız migren grubuna kıyasla daha sıktı (p=0,008). Aura varlığı ve uzamış hastalık süresi AML oluşumunda bağımsız risk faktörleri olarak anlamlı bulundu (p=0,0020 ve p=0,019). Migren atak sıklığı, allodini varlığı ve ASK skorları MWA grubunda anlamlı düzeyde daha yüksekti (sırasıyla p=0,005, p=0,015 ve p<0,001). Sonuç: Sonuçlarımız MWA hastalarında non-spesifik AML’nin aurasız gruba kıyasla daha sık olduğunu göstermektedir. Hastalık süresinin uzun olması ve aura varlığı bu lezyonların oluşumuna yatkınlık yaratmaktadır. Bulgularımızın ileride daha geniş hasta sayıları ile planlanacak çalışmalar ile desteklenmesi gerekmektedir

🔖

Cite This Article

ATALAR, A. Ç., YALIN, O. Ö. (2020). Evaluation of Non-specific Cerebral White Matter Lesions and Related Factors in Patients with Migraine with Aura. Haseki Tıp Bülteni, Cilt: 58 - Sayı: 2, 122–128. https://ajindex.com/articles/158591

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population based cohort: the GEM study. Neurology 1999;53:537-42
  2. Alemdar M, Selekler M. Migren ve kortikal yayılan depresyon. Ağrı 2006; 18: 24-30
  3. Ertas M, Baykan B, Orhan EK et al. One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain 2012;13:147-57
  4. Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol 2017;16:76-87
  5. Uggetti C, Squarza S, Longaretti F, et al. Migraine with aura and white matter lesions: an MRI study. Neurol Sci 2017;38:11-13
  6. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427- 34
  7. Colombo B, Dalla Libera D and Comi G. Brain White matter lesions in migraine: what’s the meaning? Neurol Sci 2011;32:S37-40
  8. Kamson DO, Illés Z, Aradi M, et al. Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis. J Clin Neurosci 2012;19:696-701
  9. Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts: the age gene/ environment susceptibility—Reykjavik Study. JAMA 2009;301:2563-70
  10. Olesen J, for the Third International Headache Classification Committee of the International Headache Society: New plans for headache classification: ICHD-3. Editorial. Cephalalgia 2011;31:4-5
  11. Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Research in Nursing and Health 1990;13:227-36
  12. Hawker GA, Mian S, Kendzerska T, French M. Measures of Adult Pain Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res 2011;63: 240- 52
  13. Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population. Ann Neurol 2008; 63:148-58
  14. Yalın OÖ, Uludüz D, Sungur MA, Sart H, Özge A. Identification of allodynic migraine patients with the turkish version of the allodynia symptom checklist: Reliability and consistency study. Noro Psikiyatr Ars 2017;54:260-66
  15. Ekizoglu